PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31365099-1 2019 CONTEXT: Single nucleotide polymorphisms (SNPs) of the vitamin D binding protein encoding GC (group component) gene affect 25-hydroxyvitamin D (25OHD) concentrations but their influence on vitamin D status and response to vitamin D supplementation in infants is unknown. 25-hydroxyvitamin D 123-142 GC vitamin D binding protein Homo sapiens 55-80 30712059-1 2019 BACKGROUND: Polymorphic alleles of the vitamin D (vitD)-binding protein (VDBP) gene are associated with discriminatory differences in circulating concentrations of 25-hydroxyvitamin D (25-D), the indicator of vitD status (sufficiency defined by the Endocrine Society as >=75 nmol/L). 25-hydroxyvitamin D 164-183 GC vitamin D binding protein Homo sapiens 73-77 30785996-1 2019 CONTEXT: Total 25-hydroxyvitamin D [25(OH)D] is mainly bound to vitamin d-binding protein (DBP). 25-hydroxyvitamin D 15-34 GC vitamin D binding protein Homo sapiens 64-89 30130523-0 2018 Measured free 25-hydroxyvitamin D in healthy children and relationship to total 25-hydroxyvitamin D, calculated free 25-hydroxyvitamin D and vitamin D binding protein. 25-hydroxyvitamin D 14-33 GC vitamin D binding protein Homo sapiens 141-166 30661702-0 2019 Associations of vitamin D binding protein variants with the vitamin D-induced increase in serum 25-hydroxyvitamin D. 25-hydroxyvitamin D 96-115 GC vitamin D binding protein Homo sapiens 16-41 30651747-0 2019 The GC2 haplotype of the vitamin D binding protein is a risk factor for a low plasma 25-hydroxyvitamin D concentration in a Han Chinese population. 25-hydroxyvitamin D 85-104 GC vitamin D binding protein Homo sapiens 25-50 33636926-4 2018 The number of available methods increased, but with that came a larger focus on the challenges of measuring 25-hydroxyvitamin D accurately due to binding to vitamin D-binding protein and the presence of other vitamin D metabolites. 25-hydroxyvitamin D 108-127 GC vitamin D binding protein Homo sapiens 157-182 28278285-0 2017 Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study. 25-hydroxyvitamin D 93-112 GC vitamin D binding protein Homo sapiens 19-44 28990783-1 2017 Vitamin-D-binding protein (VDBP), a transporter of 25-hydroxyvitamin D metabolites, has three common isoforms. 25-hydroxyvitamin D 51-70 GC vitamin D binding protein Homo sapiens 0-25 28990783-1 2017 Vitamin-D-binding protein (VDBP), a transporter of 25-hydroxyvitamin D metabolites, has three common isoforms. 25-hydroxyvitamin D 51-70 GC vitamin D binding protein Homo sapiens 27-31 29264568-1 2017 Context: Changes in vitamin D binding protein (DBP) concentrations and catabolism of 25-hydroxyvitamin D to 24,25-dihydroxyvitamin D (24,25D) after vitamin D2 supplementation may alter concentrations and bioavailability of circulating 25-hydroxyvitamin D (25D). 25-hydroxyvitamin D 235-254 GC vitamin D binding protein Homo sapiens 20-45 28241988-3 2017 We investigated whether maternal genetic variation in GC, the gene encoding vitamin-D binding protein, modulates the relationship between 25-hydroxyvitamin D [25(OH)D] levels and infant birth weight. 25-hydroxyvitamin D 138-157 GC vitamin D binding protein Homo sapiens 76-101 29357898-1 2018 BACKGROUND: To determine longitudinally the relationship between serum 25-hydroxyvitamin D (vitamin D) and vitamin D-binding protein (DBP) levels in mother-neonate pairs and evaluate the efficiency of prophylactic vitamin D on lactation days 45-60. 25-hydroxyvitamin D 71-90 GC vitamin D binding protein Homo sapiens 107-132 29301185-1 2017 PURPOSE: Vitamin D deficiency is reported to be more common in type 1 diabetes patients and might be associated with the increased urinary loss of vitamin D binding protein (VDBP) consequent to impaired 25-hydroxyvitamin D (25(OH)D) circulation. 25-hydroxyvitamin D 203-222 GC vitamin D binding protein Homo sapiens 174-178 28492143-1 2017 Recent studies suggest that the concentration and genotype of vitamin D binding protein (VDBP) are important factors that determine the bioavailability of 25-hydroxyvitamin D [25(OH)D] in blood. 25-hydroxyvitamin D 155-174 GC vitamin D binding protein Homo sapiens 62-87 28492143-1 2017 Recent studies suggest that the concentration and genotype of vitamin D binding protein (VDBP) are important factors that determine the bioavailability of 25-hydroxyvitamin D [25(OH)D] in blood. 25-hydroxyvitamin D 155-174 GC vitamin D binding protein Homo sapiens 89-93 26602143-1 2016 Patients with significant proteinuria represent a unique population with respect to vitamin D status due to the urinary losses of vitamin D-binding protein (DBP) to which >99 % of circulating 25-hydroxy vitamin D (25(OH)D) is bound. 25-hydroxyvitamin D 195-215 GC vitamin D binding protein Homo sapiens 130-155 27007693-0 2016 Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations. 25-hydroxyvitamin D 5-24 GC vitamin D binding protein Homo sapiens 36-61 27313313-14 2016 Single-nucleotide polymorphisms in the vitamin D binding protein gene were independently associated with lower 25-hydroxy-vitamin D and higher 24,25-dihydroxy-vitamin D. 25-hydroxyvitamin D 111-131 GC vitamin D binding protein Homo sapiens 39-64 24740207-2 2014 Vitamin D-binding protein (DBP) is the primary carrier of vitamin D in the circulation and regulates the bioavailability of 25-hydroxyvitamin D. 25-hydroxyvitamin D 124-143 GC vitamin D binding protein Homo sapiens 0-25 26383826-2 2015 The aim of this study was to identify the relationship between 25-hydroxyvitamin D [25-(OH) VD] status and the nonsynonymous single-nucleotide polymorphisms (SNPs) (rs7041 and rs4588) of the GC gene, which encodes the vitamin D binding protein, and one SNP (rs10741657) near the CYP2R1 gene. 25-hydroxyvitamin D 63-82 GC vitamin D binding protein Homo sapiens 218-243 25350643-1 2014 BACKGROUND: Observational studies have shown that vitamin D binding protein (DBP) levels, a key determinant of 25-hydroxy-vitamin D (25OHD) levels, and 25OHD levels themselves both associate with risk of disease. 25-hydroxyvitamin D 111-131 GC vitamin D binding protein Homo sapiens 50-75 25904602-1 2015 BACKGROUND: Vitamin D-binding protein (DBP) is the primary carrier of 25-hydroxyvitamin D [25(OH)D] in the circulation. 25-hydroxyvitamin D 70-89 GC vitamin D binding protein Homo sapiens 12-37 25863973-0 2015 Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study. 25-hydroxyvitamin D 80-99 GC vitamin D binding protein Homo sapiens 9-34 24822065-1 2014 Vitamin D binding protein (DBP) may alter the biologic activity of 25-hydroxyvitamin D [25(OH)D]. 25-hydroxyvitamin D 67-86 GC vitamin D binding protein Homo sapiens 0-25 24472850-2 2014 Gc-globulin (GC) isotypes, based on rs7041 and rs4588 diplotypes, have varying affinities for 1alpha,25-dihydroxyvitamin D (1,25(OH)2D) and 25-hydroxyvitamin D (25(OH)D), which may affect circulating metabolite concentration as well as delivery at the cellular level. 25-hydroxyvitamin D 140-159 GC vitamin D binding protein Homo sapiens 0-11 24383929-1 2014 In the circulation 25-hydroxyvitamin D (25(OH)D) is bound to vitamin D-binding protein (DBP) and albumin. 25-hydroxyvitamin D 19-38 GC vitamin D binding protein Homo sapiens 61-86 24857306-1 2014 OBJECTIVE: To assess the correlation of serum 25-hydroxyvitamin D (25-OHD) levels with vitamin D-binding protein (the group-specific component, GC) gene polymorphism in chronic obstructive pulmonary disease (COPD). 25-hydroxyvitamin D 46-65 GC vitamin D binding protein Homo sapiens 87-112 24498064-0 2014 Vitamin D binding protein genotype is associated with serum 25-hydroxyvitamin D and PTH concentrations, as well as bone health in children and adolescents in Finland. 25-hydroxyvitamin D 60-79 GC vitamin D binding protein Homo sapiens 0-25 24987416-1 2014 Vitamin D binding protein (DBP) is the major carrier protein of 25-hydroxyvitamin D (25(OH) D) in the circulation, where it may serve roles in maintaining stable levels during times of decreased 25(OH) availability and in regulating delivery of 25(OH) D to target tissues. 25-hydroxyvitamin D 64-83 GC vitamin D binding protein Homo sapiens 0-25 25388159-0 2014 Erratum to "Influence of Vitamin D Binding Protein on Accuracy of 25-Hydroxyvitamin D Measurement Using the ADVIA Centaur Vitamin D Total Assay". 25-hydroxyvitamin D 66-85 GC vitamin D binding protein Homo sapiens 25-50 24170105-1 2014 CONTEXT: We hypothesized that, similar to the coordinated homeostatic regulation of most hormones, the concentration of free and bioavailable 25-hydroxyvitamin D [25(OH)D] will be tightly controlled by total 25(OH)D and vitamin D binding protein (VDBP) and that the VDBP concentrations will be associated with insulin resistance status. 25-hydroxyvitamin D 142-161 GC vitamin D binding protein Homo sapiens 220-245 24170105-1 2014 CONTEXT: We hypothesized that, similar to the coordinated homeostatic regulation of most hormones, the concentration of free and bioavailable 25-hydroxyvitamin D [25(OH)D] will be tightly controlled by total 25(OH)D and vitamin D binding protein (VDBP) and that the VDBP concentrations will be associated with insulin resistance status. 25-hydroxyvitamin D 142-161 GC vitamin D binding protein Homo sapiens 247-251 24170105-1 2014 CONTEXT: We hypothesized that, similar to the coordinated homeostatic regulation of most hormones, the concentration of free and bioavailable 25-hydroxyvitamin D [25(OH)D] will be tightly controlled by total 25(OH)D and vitamin D binding protein (VDBP) and that the VDBP concentrations will be associated with insulin resistance status. 25-hydroxyvitamin D 142-161 GC vitamin D binding protein Homo sapiens 266-270 24868205-0 2014 Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions. 25-hydroxyvitamin D 36-55 GC vitamin D binding protein Homo sapiens 0-25 23556437-0 2013 Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D3 or D2supplementation. 25-hydroxyvitamin D 23-42 GC vitamin D binding protein Homo sapiens 56-81 23924835-0 2013 Genetic variant in vitamin D binding protein is associated with serum 25-hydroxyvitamin D and vitamin D insufficiency in southern Chinese. 25-hydroxyvitamin D 70-89 GC vitamin D binding protein Homo sapiens 19-44 23425651-1 2013 OBJECTIVE: To determine whether low levels of vitamin D-binding protein (DBP) are related to 25-hydroxyvitamin D (25[OH]D) deficiency in female patients with primary hyperparathyroidism (PHPT). 25-hydroxyvitamin D 93-112 GC vitamin D binding protein Homo sapiens 46-71 22841398-8 2013 The inverse association between ascorbic acid and vitamin D binding protein was highest in those with higher levels of serum 25-hydroxyvitamin D. 25-hydroxyvitamin D 125-144 GC vitamin D binding protein Homo sapiens 50-75 23548751-0 2013 Variations in the vitamin D-binding protein (DBP) gene are related to lower 25-hydroxyvitamin D levels in healthy girls: a cross-sectional study. 25-hydroxyvitamin D 76-95 GC vitamin D binding protein Homo sapiens 18-43 19116321-0 2009 Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. 25-hydroxyvitamin D 84-103 GC vitamin D binding protein Homo sapiens 29-54 22699377-1 2012 Most of the major vitamin D metabolites 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D circulates in a tightly bound state to vitamin D-binding protein (DBP), rendering this fraction unavailable for biological action. 25-hydroxyvitamin D 40-59 GC vitamin D binding protein Homo sapiens 127-152 22081234-2 2012 The aim of our study was to determine whether losses of vitamin D binding protein [VDBP] in urine and dialysate contribute to circulating 25-hydroxyvitamin D [25OHD] levels in chronic peritoneal dialysis [PD] patients. 25-hydroxyvitamin D 138-157 GC vitamin D binding protein Homo sapiens 56-81 22081234-2 2012 The aim of our study was to determine whether losses of vitamin D binding protein [VDBP] in urine and dialysate contribute to circulating 25-hydroxyvitamin D [25OHD] levels in chronic peritoneal dialysis [PD] patients. 25-hydroxyvitamin D 138-157 GC vitamin D binding protein Homo sapiens 83-87 22232734-0 2012 Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. 25-hydroxyvitamin D 82-101 GC vitamin D binding protein Homo sapiens 22-47 21684333-1 2011 Variants of the vitamin D binding protein (VDBP) gene appear to be associated with levels of the main circulating vitamin D metabolite, 25-hydroxyvitamin D [(25(OH)D]. 25-hydroxyvitamin D 136-155 GC vitamin D binding protein Homo sapiens 16-41 21684333-1 2011 Variants of the vitamin D binding protein (VDBP) gene appear to be associated with levels of the main circulating vitamin D metabolite, 25-hydroxyvitamin D [(25(OH)D]. 25-hydroxyvitamin D 136-155 GC vitamin D binding protein Homo sapiens 43-47 19302999-0 2009 Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. 25-hydroxyvitamin D 104-123 GC vitamin D binding protein Homo sapiens 31-56 22887780-0 2013 Vitamin D binding protein is a key determinant of 25-hydroxyvitamin D levels in infants and toddlers. 25-hydroxyvitamin D 50-69 GC vitamin D binding protein Homo sapiens 0-25 22576297-1 2012 UNLABELLED: Recently, genome-wide studies identified genetic variants that affect serum 25-hydroxyvitamin D levels in healthy populations (rs12785878, near dehydrocholesterol reductase, DHCR7; rs10741657, at CYP2R1; and rs7041, at vitamin D binding protein, GC). 25-hydroxyvitamin D 88-107 GC vitamin D binding protein Homo sapiens 231-256 19303961-1 2009 25-Hydroxy vitamin D (25OHD) is lipophilic and highly bound to vitamin D-binding protein (VDBP) in plasma. 25-hydroxyvitamin D 0-20 GC vitamin D binding protein Homo sapiens 63-88 19303961-1 2009 25-Hydroxy vitamin D (25OHD) is lipophilic and highly bound to vitamin D-binding protein (VDBP) in plasma. 25-hydroxyvitamin D 0-20 GC vitamin D binding protein Homo sapiens 90-94 2078829-6 1990 A technical outcome of this study is that of the species tested, vitamin D binding protein from rat serum is the most suitable as a reagent component for methods used to measure total 25-hydroxyvitamin D by competitive protein binding assay. 25-hydroxyvitamin D 184-203 GC vitamin D binding protein Homo sapiens 65-90 15868280-0 2005 Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. 25-hydroxyvitamin D 25-45 GC vitamin D binding protein Homo sapiens 111-136 3958856-0 1986 Seasonal differences in serum vitamin D binding protein in exclusively breast-fed infants: negative relationship to sunshine exposure and 25-hydroxyvitamin D. 25-hydroxyvitamin D 138-157 GC vitamin D binding protein Homo sapiens 30-55 3745408-0 1986 Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. 25-hydroxyvitamin D 35-54 GC vitamin D binding protein Homo sapiens 102-127 33188595-1 2021 BACKGROUND: 25-Hydroxyvitamin D [25(OH)D] may be a poor marker of vitamin D status as it reflects differences in vitamin D binding protein (VDBP) between individuals. 25-hydroxyvitamin D 12-31 GC vitamin D binding protein Homo sapiens 113-138 33188595-1 2021 BACKGROUND: 25-Hydroxyvitamin D [25(OH)D] may be a poor marker of vitamin D status as it reflects differences in vitamin D binding protein (VDBP) between individuals. 25-hydroxyvitamin D 12-31 GC vitamin D binding protein Homo sapiens 140-144 885987-8 1977 From these data the following conclusions can be drawn: 1) The serum concentration of the vitamin D-binding protein (about 6.10(-6)M) largely exceeds the normal serum concentration of 25-hydroxy vitamin D (about 4.10(-8)M), so that this protein is normally for less than 1% saturated, 2) Normal serum levels of the vitamin D-binding protein were observed in several diseases of calcium metabolism, and 3) The free concentration of 25-hydroxyvitamin D is not regulated at a constant level. 25-hydroxyvitamin D 184-204 GC vitamin D binding protein Homo sapiens 90-115 885987-8 1977 From these data the following conclusions can be drawn: 1) The serum concentration of the vitamin D-binding protein (about 6.10(-6)M) largely exceeds the normal serum concentration of 25-hydroxy vitamin D (about 4.10(-8)M), so that this protein is normally for less than 1% saturated, 2) Normal serum levels of the vitamin D-binding protein were observed in several diseases of calcium metabolism, and 3) The free concentration of 25-hydroxyvitamin D is not regulated at a constant level. 25-hydroxyvitamin D 431-450 GC vitamin D binding protein Homo sapiens 90-115 33867707-2 2021 This enigma of widespread VDD needs exploration especially among under-fives as physiological variations in Vitamin D Binding Protein (VDBP) levels could be potential confounders in the interpretation of total 25-hydroxyvitamin D [25(OH)D]. 25-hydroxyvitamin D 210-229 GC vitamin D binding protein Homo sapiens 135-139 32712661-0 2020 In Reply: The Causal Relationship of Total and Free 25-Hydroxyvitamin D and Vitamin D Binding Protein with Risk of Osteoporotic Fractures. 25-hydroxyvitamin D 52-71 GC vitamin D binding protein Homo sapiens 76-101